GSK’s Post

View organization page for GSK, graphic

4,201,450 followers

Emma Walmsley has been named Britain's Most Admired Leader 2024. Watch Emma and Dame Julia Hoggett, CEO London Stock Exchange, discuss Emma’s ambition and optimism for GSK in 2025. GSK is focussed on delivering innovation that brings benefit for patients, and sustainable value to shareholders. The Most Admired survey, conducted by Echo Research in partnership with the London Stock Exchange, is the longest running corporate reputation survey in the UK, celebrating British leadership and excellence. #BritainsMostAdmired2024

She completely deserves this recognition. She earned it!!! Extremely impressive and highly regarded female leader. Honors given when so truly earned and deserved is so meaningful. This is what true inspiration looks like!!

Sonam Wagh

Microbiologist at GSK

1w

Heartiest congratulations mam! You deserve and you earn! Proud to be a part of GSK family.

Like
Reply

Strong and innovative leader, a woman of great influence and team leadership

Like
Reply
Peter Hawthorne

Business Services Transformation Consultant

2w

If you speak to staff and shareholders they may not have the same opinion

Jason Oliver

Business Development executive (formulation scientist), LION over 14,500 connections

2w

Congrats! Great to see GSK growing

Like
Reply

Congratulations, very well deserved! 🌟 🏆

Maria Malilis

🏹 PROCESS & KNOWLEDGE CONSULTANT —————————————————————— ✨« Innovation is the ability to see what everyone seen and to think what no one thought » ASG

2w

I had the opportunity to « see » her give a live speech to all of GSK, and I was impressed by her charisma and her perfect command of her presence and speech. Very amazing and inspiring true leader.

Impressive leadership! Emma's vision for GSK’s future is inspiring!

Like
Reply
Mike Lewyckyj

Maintenance Technician at GSK

1w

I'll save my congratulations till the market affirms this with at least a $65 share price. Our lifetime GSK nest egg is too small for retirement................

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics